Latest Adalimumab Stories

2011-03-01 08:00:00

SAN DIEGO, March 1, 2011 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today highlighted its financial results and product development progress for the year ended December 31, 2010. "Prometheus had another record year in 2010, our 14th consecutive year of sales growth," said Joseph M.

2011-02-16 12:48:38

Some biologic drugs may be safer than others according to a new systematic review by Cochrane researchers.

2011-01-26 06:44:00

ABBOTT PARK, Ill., Jan. 26, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2010. Diluted earnings per share, excluding specified items, were $1.30, reflecting 10.2 percent growth.

2010-12-20 09:00:00

EXTON, Pa., Dec. 20, 2010 /PRNewswire/ -- In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc.

2010-11-03 08:48:00

EXTON, Pa., Nov. 3, 2010 /PRNewswire/ -- Bio-Trends is pleased to announce the publication of a new syndicated report, TreatmentTrends®: Rheumatoid Arthritis Q3 2010. This report covers the use of biologics for the treatment of rheumatoid arthritis (RA).

Word of the Day
  • A young chicken: also used as a pet name for children.
The word 'chickabiddy' may come from 'chick' plus 'biddy', a name used in calling a hen or chicken.